** Shares of telehealth company Doximity Inc DOCS.N up
15.12% to $23.60 in premarket trading
** Co sees FY24 revenue between $460 mln and $472 mln vs
prior forecast of $452 mln- $468 mln
** Forecasts Q3 revenue between $127 mln and $128 mln
** DOCS on Thursday posted Q2 revenue of $113.6 mln vs LSEG
estimate of $109.1 mln
** 5 of 17 brokerages rate the stock "buy" or higher, 9
"hold" and 3 "sell"; their median PT is $25- LSEG
** Up to last close, stock had fallen 38.9% YTD
(Reporting by Juby Babu in Bengaluru)
((Juby.Babu@thomsonreuters.com;))